There’s a growing body of evidence demonstrating technology-led digital transformations are overpromising and under-delivering returns on investment for
A publicly-listed biopharmaceutical company with three clinically advanced products in development, XORTX Therapeutics’ focus is on developing drugs for kidney disease treatment, an area where there is a large unmet